Marie-Rose Christiaens
Overview
Explore the profile of Marie-Rose Christiaens including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
64
Citations
2749
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Van Bockstal M, Lambein K, Smeets A, Slembrouck L, Neven P, Nevelsteen I, et al.
Eur J Surg Oncol
. 2018 Nov;
45(4):550-559.
PMID: 30454971
Background: Ductal carcinoma in situ (DCIS) of the breast constitutes a heterogeneous group of non-obligate precursors for invasive breast cancer. To date, adequate risk stratification is lacking, which is presumed...
2.
Devoogdt N, Geraerts I, Van Kampen M, De Vrieze T, Vos L, Neven P, et al.
J Physiother
. 2018 Sep;
64(4):245-254.
PMID: 30241913
Question: What are the short-term and long-term preventive effects of manual lymph drainage (MLD), when used in addition to information and exercise therapy, on the development of lymphoedema after axillary...
3.
De Groef A, Van Kampen M, Moortgat P, Anthonissen M, Van den Kerckhove E, Christiaens M, et al.
PLoS One
. 2018 Mar;
13(3):e0193915.
PMID: 29522540
Purpose: To investigate the concurrent, face and content validity of an evaluation tool for Myofascial Adhesions in Patients after Breast Cancer (MAP-BC evaluation tool). Methods: 1) Concurrent validity of the...
4.
De Groef A, Van Kampen M, Vervloesem N, Dieltjens E, Christiaens M, Neven P, et al.
Clin Rehabil
. 2017 Sep;
32(4):451-461.
PMID: 28914087
Objective: To investigate the effect of myofascial therapy in addition to a standard physical therapy program for treatment of persistent arm pain after finishing breast cancer treatment. Design: Double-blinded (patient...
5.
De Groef A, Van Kampen M, Vervloesem N, De Geyter S, Dieltjens E, Christiaens M, et al.
PLoS One
. 2017 Jun;
12(6):e0179116.
PMID: 28598978
Purpose: To develop a tool to evaluate myofascial adhesions objectively in patients with breast cancer and to investigate its interrater reliability. Methods: 1) Development of the evaluation tool. Literature was...
6.
De Groef A, Van Kampen M, Vervloesem N, De Geyter S, Christiaens M, Neven P, et al.
Clin Rehabil
. 2017 May;
31(12):1625-1635.
PMID: 28523988
Objective: To investigate the effects of myofascial techniques, in addition to a standard physical therapy programme for upper limb pain shortly after breast cancer surgery. Design: Double-blinded (patient and assessor)...
7.
De Groef A, Meeus M, De Vrieze T, Vos L, Van Kampen M, Christiaens M, et al.
Musculoskelet Sci Pract
. 2017 Mar;
29:52-59.
PMID: 28319882
Purpose: The aim of this study was to explore the treatment, patient, and impairment-related risk factors associated with upper limb dysfunctions in breast cancer survivors. Methods: A cross-sectional study was...
8.
De Groef A, Van Kampen M, Verlvoesem N, Dieltjens E, Vos L, De Vrieze T, et al.
Support Care Cancer
. 2017 Feb;
25(7):2119-2127.
PMID: 28197849
Purpose: Besides pain, myofascial dysfunctions may contribute to the presence of upper limb impairments such as impaired range of motion, decreased strength, lymphedema, and altered postures and kinematics. Therefore, the...
9.
De Groef A, Van Kampen M, Tieto E, Schonweger P, Christiaens M, Neven P, et al.
Breast
. 2016 Aug;
29:102-8.
PMID: 27479040
Purpose: The aim of this study is (1) to investigate the prevalence rate of arm lymphedema, pain, impaired shoulder range of motion, strength and shoulder function one year after a...
10.
Luyeye Mvila G, Batalansi D, Praet M, Marchal G, Laenen A, Christiaens M, et al.
Breast
. 2015 Aug;
24(5):642-8.
PMID: 26279132
Objectives: Compared to European women, breast cancers in African women present at a younger age, with a higher tumor grade and are more often estrogen receptor (ER)/progesterone receptor (PR) negative....